Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Stock Down 11.3 Percent on Poor Q1 Earnings

NEW YORK (GenomeWeb News) — Shares in Affymetrix were down 11.31 percent, or $3.56, at $27.91 in mid-afternoon trading today after the company yesterday reported a 7-percent decline in revenue and a $4-million loss for the first quarter. 
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.